Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001420506-26-000249·IRADIMED CORP
Schedule 13G ownership disclosure
iRadimed Corp
Common · CUSIP: 46266A109
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nine Ten Capital Management
Shares: 428,477 · Class: 3.4%
- Nine Ten Partners LP
Shares: 428,477 · Class: 3.4%
- Russell Mollen
Shares: 428,477 · Class: 3.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001420506-26-000249
- Form type
- SCHEDULE 13G/A
- Filer
- IRADIMED CORP
- CIK
- CIK 1325618
- Filed
- Feb 10, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership